Hints and tips:
...Birgit Kulhoff, a fund manager at Rahn & Bodmer in Zurich who holds Novartis shares, said the reversal was “good news” shareholders....
...Daniel Vasella confirmed on Monday that he would receive SFr72m ($78m) in exchange for providing continuing advice and agreeing not to offer information to competitors of the Swiss pharmaceutical group,...
...Since news of Novartis’s planned $78m pay-off to Daniel Vasella broke last Friday, the Swiss pharmaceuticals giant and its departing chairman have been hit by a deluge of criticism....
International Edition